Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
85,843,278
-
Share change
-
-11,288,203
-
Total reported value
-
$7,142,041,273
-
Put/Call ratio
-
151%
-
Price per share
-
$83.20
-
Number of holders
-
693
-
Value change
-
-$900,162,200
-
Number of buys
-
236
-
Number of sells
-
327
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2023
As of 30 Jun 2023,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
693 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,843,278 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, JPMORGAN CHASE & CO, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SNC, Phoenix Holdings Ltd., JANE STREET GROUP, LLC, BROWN ADVISORY INC, and Alaska Permanent Fund Corp.
This page lists
703
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.